Opana and Mometasone furoate drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Opana and Mometasone furoate. Common interactions include glycosylated haemoglobin increased among females.

The phase IV clinical study analyzes what interactions people who take Opana and Mometasone furoate have. It is created by eHealthMe based on reports of 12 people who take Opana and Mometasone furoate from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Nov, 30, 2022

12 people who take Opana and Mometasone furoate together, and have interactions are studied.


What is Opana?

Opana has active ingredients of oxymorphone hydrochloride. It is often used in pain. eHealthMe is studying from 34,596 Opana users for its effectiveness, alternative drugs and more.

What is Mometasone furoate?

Mometasone furoate has active ingredients of mometasone furoate. It is often used in asthma. eHealthMe is studying from 8,101 Mometasone furoate users for its effectiveness, alternative drugs and more.

Number of Opana and Mometasone furoate reports submitted per year:

Opana and Mometasone furoate drug interactions.

Common Opana and Mometasone Furoate drug interactions by gender *:

female:

  1. Glycosylated haemoglobin increased
  2. Hypopnoea
  3. Sexual abuse
  4. Urinary tract infection
  5. Vasculitis
  6. Migraine
  7. Sleep apnoea syndrome
  8. Systemic lupus erythematosus
  9. Weight decreased
  10. Abdominal pain upper

male:

n/a

Common Opana and Mometasone Furoate drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Abdominal pain upper

40-49:

n/a

50-59:

n/a

60+:

n/a

Common conditions people have *:

  1. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 9 people, 75.00%
  2. Nasopharyngitis (inflammation of the nasopharynx): 2 people, 16.67%
  3. Rickets (softening of bones): 2 people, 16.67%
  4. Fungal Infection: 2 people, 16.67%
  5. Fluid Retention (an abnormal accumulation of fluid in the blood): 2 people, 16.67%
  6. Fibromyalgia (a long-term condition which causes pain all over the body): 2 people, 16.67%
  7. Hypersensitivity: 2 people, 16.67%
  8. Ill-Defined Disorder: 2 people, 16.67%
  9. Infection: 2 people, 16.67%
  10. Inflammation: 2 people, 16.67%

* Approximation only. Some reports may have incomplete information.

Do you take Opana and Mometasone furoate?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Opana and Mometasone furoate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Opana side effects:

Browse all side effects of Opana:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Mometasone furoate side effects:

Browse all side effects of Mometasone furoate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Opana interactions:

Browse all interactions between Opana and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Mometasone furoate interactions:

Browse all interactions between Mometasone furoate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on oxymorphone hydrochloride and mometasone furoate (the active ingredients of Opana and Mometasone furoate, respectively), and Opana and Mometasone furoate (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Opana and Mometasone furoate.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: